Sharechat Logo

Pernod Ricard's Millstream unit turns to loss on goodwill impairment

Thursday 4th January 2018

Text too small?

Pernod Ricard’s New Zealand unit turned to a loss in 2017 after it booked a $150 million goodwill impairment.

The liquor group's Millstream Equities posted a $136.2 million loss in the year to June 30, 2017, from a $7.4 million profit a year earlier. Revenue rose to $248 million from $241 million a year earlier, while cost of sales increased to $178 million from $160 million the prior year.

Millstream Equities owns a number of New Zealand wine brands including Church Road, Brancott Estate and Stoneleigh. Its French-listed parent, Pernod Ricard SA, last traded at 131.20 euros, up 26 percent in the last 12 months. 

The impairment left the group calculating goodwill at $157.7 million, compared to $307.7 million in 2016. Notes to the accounts said the goodwill balance relates to the historical acquisitions of Montana Group by Millstream Equities in 2001.

Operating expenses increased tenfold to $196 million, including the large goodwill impairment. Within that category, the company also spent $16.5 million on earthquake business continuity and repairs, up from $4.9 million a year earlier.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors